The Africa Gazette
SEE OTHER BRANDS

The latest news from Africa

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on June 4, 2025

Altcoin-Focused Cloud Mining Contracts Launch as Dogecoin Breaks Resistance

Altcoin-Focused Cloud Mining Contracts Launch as Dogecoin Breaks Resistance

New York, USA, June 04, 2025 (GLOBE NEWSWIRE) -- As Dogecoin breaks a key resistance level with a 2.4% rally, driven by institutional interest and renewed community engagement, global cloud mining platform HashFly has announced a strategic update to its …

Hudbay Provides an Update on Manitoba Operations due to Wildfire Evacuation Order

Hudbay Provides an Update on Manitoba Operations due to Wildfire Evacuation Order

TORONTO, June 04, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) continues to respond to the evolving wildfire situation in northern Manitoba and is working closely with local authorities to ensure its employees …

AnorTech Announces Positive Results From Sustainable Cement R&D Program

AnorTech Announces Positive Results From Sustainable Cement R&D Program

VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- Vancouver, BC – ANORTECH INC. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTC “ANORF”) is pleased to announce the successful completion of the latest phase of its research and …

Biodexa Announces Recruitment of First Patient  in Phase 2 Study of Tolimidone in Type 1 Diabetes

Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of …

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

PITTSBURGH, June 04, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it …

Integral Metals Engages Geological Consultant for KAP Project Desktop Study and Resource Planning

Integral Metals Engages Geological Consultant for KAP Project Desktop Study and Resource Planning

CALGARY, Alberta, June 04, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it has engaged Understood Mineral Resources Ltd. (“UMR”), a geological and …

Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET. The …

 Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2 All three cohorts show separation from placebo with statistically significant difference from placebo at day 28 Cohort 3 demonstrates clinically meaningful reduction in itch as …

Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity

Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity

BURLINGAME, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Today, Accumulus Synergy (“Accumulus”) announced a strategic partnership with Veeva Systems (“Veeva”) focused on enabling connectivity to help the life sciences industry more effectively exchange …

Accumulus Synergy und Veeva Systems gehen eine Partnerschaft ein, um die Transformation der Regulierung und die Konnektivität voranzutreiben

Accumulus Synergy und Veeva Systems gehen eine Partnerschaft ein, um die Transformation der Regulierung und die Konnektivität voranzutreiben

BURLINGAME, Kalifornien, June 04, 2025 (GLOBE NEWSWIRE) -- Accumulus Synergy („Accumulus“) hat heute eine strategische Partnerschaft mit Veeva Systems („Veeva“) bekannt gegeben, deren Schwerpunkt auf der Bereitstellung von Konnektivität liegt, um die Life- …

アキュミュラス・シナジー (Accumulus Synergy) とヴィーバ・システムズ (Veeva Systems)、規制の変革と接続性の促進に向けて提携

アキュミュラス・シナジー (Accumulus Synergy) とヴィーバ・システムズ (Veeva Systems)、規制の変革と接続性の促進に向けて提携

カリフォルニア州バーリンゲーム発, June 04, 2025 (GLOBE NEWSWIRE) -- 本日、アキュミュラス・シナジー (「アキュミュラス」) は、ライフサイエンス業界が世界中の各国規制当局 (NRA) と規制対象情報をより効果的に交換できるよう支援することを目的とした、接続性の実現に焦点を当てたヴィーバ・システムズ (「ヴィーバ」) …

Accumulus Synergy et Veeva Systems s’associent afin d’accélérer la transformation réglementaire et la connectivité

Accumulus Synergy et Veeva Systems s’associent afin d’accélérer la transformation réglementaire et la connectivité

BURLINGAME, Calif., 04 juin 2025 (GLOBE NEWSWIRE) -- Accumulus Synergy (« Accumulus ») a annoncé aujourd’hui un partenariat stratégique avec Veeva Systems (« Veeva ») axé sur la mise en place de solutions de connectivité permettant au secteur des sciences …

Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development

Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development

MILAN, Italy and HEIDELBERG, Germany, June 04, 2025 (GLOBE NEWSWIRE) -- Axxam S.p.A., a premier provider of integrated early discovery services, and Molecular Health GmbH, a leader in artificial intelligence (AI)-driven development solutions, are …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service